M&A Deal Summary

Boston Scientific Acquires Advanced Bionics

On June 1, 2004, Boston Scientific acquired healthcare services company Advanced Bionics for 740M USD

Acquisition Highlights
  • This is Boston Scientific’s 2nd transaction in the Healthcare Services sector.
  • This is Boston Scientific’s 9th largest (disclosed) transaction.
  • This is Boston Scientific’s 7th transaction in the United States.
  • This is Boston Scientific’s 5th transaction in California.
Investment Fate
  • Advanced Bionics was divested to a consortium of strategic buyers in 2009 for 489M USD.

M&A Deal Summary

Date 2004-06-01
Target Advanced Bionics
Sector Healthcare Services
Buyer(s) Boston Scientific
Deal Type Add-on Acquisition
Deal Value 740M USD

Target

Advanced Bionics

Valencia, California, United States
Advanced Bionics develops the most advanced cochlear implant systems in the world. With operations in over 50 countries and a track record for developing high-performing, state-of-the-art products, AB’s talented, group of technologists and professionals are driven to succeed, work with integrity, and stay firmly committed to quality while delivering unmatched customer service.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States

Category Company
Founded 1979
Sector Medical Products
Employees48,000
Revenue 16.7B USD (2024)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company that offers products and technologies used to diagnose and treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.


DEAL STATS #
Overall 8 of 70
Sector: Healthcare Services M&A 2 of 8
Type: Add-on Acquisition M&A Deals 8 of 54
State: California M&A 5 of 29
Country: United States M&A 7 of 55
Year: 2004 M&A 1 of 1
Size (of disclosed) 9 of 36
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2002-07-08 BEI Medical System Co.

Teterboro, New Jersey, United States

BEI designs, manufactures and markets less-invasive technology used by gynecologists to treat excessive uterine bleeding due to benign causes. BEI's major technology is the Hydro ThermAblator(R) (HTA) System, a less-invasive technology for global endometrial ablation, a procedure designed to eliminate the tissue (the endometrium) responsible for menstrual bleeding. The HTA System allows gynecologists to perform endometrial ablation under direct visualization on an outpatient basis under local anesthesia. More than 200,000 hysterectomies are performed each year in the U.S. for excessive uterine bleeding due to benign causes.

Buy $95M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-04-18 TriVascular

Santa Rosa, California, United States

TriVascular, Inc. is a medical device company that design and manufacture endovascular aortic repair (EVAR). TriVascular’s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR.

Buy -